Clinical Trial Update: FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE) [Phase 2]

View source ↗

Summary

Phase 2 FORCE trial evaluating focal radiation for oligometastatic castration-resistant prostate cancer has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2026-01-15